Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2020

Nov 6, 2020

30016_dirs_2020-11-06_d4acd1fe-933d-461d-9017-9f0e98038b1a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-11-05

Reporting Person: Hunt Nimrata (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-05 Common Stock S 2098 $470.0801 Disposed 7571 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 160 Indirect

Footnotes

F1: Includes 17 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2020.